{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:48:58Z","timestamp":1790315338132,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.urolonc.2015.05.008","type":"journal-article","created":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T06:51:54Z","timestamp":1434178314000},"page":"496.e17-496.e23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Adjuvant chemotherapy is associated with improved overall survival in pelvic node\u2013positive penile cancer after lymph node dissection: A multi-institutional study"],"prefix":"10.1016","volume":"33","author":[{"given":"Pranav","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Djajadiningrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Zargar-Shoshtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Catanzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Nicolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Horenblas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe E.","family":"Spiess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2015.05.008_bib1","first-page":"9","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2015.05.008_bib2","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s00345-013-1024-4","article-title":"The risk factors for the presence of pelvic lymph node metastasis in penile squamous cell carcinoma patients with inguinal lymph node dissection","volume":"31","author":"Liu","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2015.05.008_bib3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.juro.2013.10.140","article-title":"The relationship between characteristics of inguinal lymph nodes and pelvic lymph node involvement in penile squamous cell carcinoma: a single institution experience","volume":"191","author":"Lughezzani","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2015.05.008_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/SPC.0000000000000075","article-title":"Managing advanced penile cancer in 2014","volume":"8","author":"Blais","year":"2014","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.urolonc.2015.05.008_bib5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/SPC.0b013e32833efcca","article-title":"Therapeutic strategies for advanced penile carcinoma","volume":"4","author":"Delacroix","year":"2010","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.urolonc.2015.05.008_bib6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.ju.0000062829.43654.5e","article-title":"Advanced penile carcinoma","volume":"170","author":"Culkin","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2015.05.008_bib7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","article-title":"EAU guidelines on penile cancer: 2014 update","volume":"67","author":"Hakenberg","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2015.05.008_bib8","doi-asserted-by":"crossref","first-page":"659","DOI":"10.6004\/jnccn.2013.0195","article-title":"New treatment guidelines for penile cancer","volume":"11","author":"Spiess","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.urolonc.2015.05.008_bib9","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.urolonc.2015.05.008_bib10","doi-asserted-by":"crossref","first-page":"E661","DOI":"10.1111\/j.1464-410X.2012.11453.x","article-title":"Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis","volume":"110","author":"Di Lorenzo","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2015.05.008_bib11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/0974-7796.102659","article-title":"Role of paclitaxel and platinum-based adjuvant chemotherapy in high-risk penile cancer","volume":"4","author":"Noronha","year":"2012","journal-title":"Urol Ann"},{"key":"10.1016\/j.urolonc.2015.05.008_bib12","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3109\/02841868809094366","article-title":"Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis","volume":"27","author":"Pizzocaro","year":"1988","journal-title":"Acta Oncol"},{"key":"10.1016\/j.urolonc.2015.05.008_bib13","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1046\/j.1464-410x.2000.00862.x","article-title":"Iliac nodal metastases from carcinoma of the penis treated surgically","volume":"86","author":"Lopes","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2015.05.008_bib14","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.urology.2010.03.003","article-title":"Epidemiology and natural history of penile cancer","volume":"76","author":"Pow-Sang","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2015.05.008_bib15","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1464-410X.2006.06496.x","article-title":"Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma","volume":"98","author":"Hakenberg","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2015.05.008_bib16","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1464-410X.1983.tb03366.x","article-title":"Adjuvant treatment using bleomycin in squamous cell carcinoma of penis: study of 19 cases","volume":"55","author":"Maiche","year":"1983","journal-title":"Br J Urol"},{"key":"10.1016\/j.urolonc.2015.05.008_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000480874","article-title":"Up-to-date management of carcinoma of the penis","volume":"32","author":"Pizzocaro","year":"1997","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2015.05.008_bib18","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/annonc\/mds635","article-title":"Penile cancer: current therapy and future directions","volume":"24","author":"Sonpavde","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urolonc.2015.05.008_bib19","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.juro.2006.11.038","article-title":"Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma","volume":"177","author":"Bermejo","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2015.05.008_bib20","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.eururo.2007.02.006","article-title":"Neoadjuvant chemotherapy in advanced penile carcinoma","volume":"52","author":"Leijte","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2015.05.008_bib21","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","article-title":"Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study","volume":"28","author":"Pagliaro","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2015.05.008_bib22","article-title":"Prognostic factors influencing survival from regionally advanced squamous cell carcinoma of the penis after preoperative chemotherapy","author":"Dickstein","year":"2014","journal-title":"BJU Int"},{"issue":"Suppl 6","key":"10.1016\/j.urolonc.2015.05.008_bib23","doi-asserted-by":"crossref","first-page":"vi115","DOI":"10.1093\/annonc\/mdt286","article-title":"Penile cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Van Poppel","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urolonc.2015.05.008_bib24","doi-asserted-by":"crossref","unstructured":"Giannatempo P, Paganoni A, Sangalli L, et al. Survival analyses of adjuvant or neoadjuvant combination of a taxane plus cisplatin and 5-fluorouracil (T-PF) in patients with bulky nodal metastases from squamous cell carcinoma of the penis (PSCC): results of a single high-volume center. Presented at the American Society Of Clinical Oncology, 2014.","DOI":"10.1200\/jco.2014.32.4_suppl.377"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143915002318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143915002318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:07:02Z","timestamp":1761041222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143915002318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1078143915002318"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2015.05.008","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant chemotherapy is associated with improved overall survival in pelvic node\u2013positive penile cancer after lymph node dissection: A multi-institutional study","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2015.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}